Loading…

Deletion of adipocyte prohibitin 1 exacerbates high‐fat diet‐induced steatosis but not liver inflammation and fibrosis

Adipose tissue dysfunction is closely associated with the development and progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have implied an important role of prohibitin‐1 (PHB1) in adipose tissue function. In the current study, we aimed to explore the function of adipocyte PHB1...

Full description

Saved in:
Bibliographic Details
Published in:Hepatology communications 2022-12, Vol.6 (12), p.3335-3348
Main Authors: Wang, Xiaolin, Kim, Seung‐Jin, Guan, Yukun, Parker, Richard, Rodrigues, Robim M., Feng, Dechun, Lu, Shelly C., Gao, Bin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5092-f3e93a28a37e7daa4661e2892321539e8b892c558d7c2dd20b190d413c0c6ddc3
cites cdi_FETCH-LOGICAL-c5092-f3e93a28a37e7daa4661e2892321539e8b892c558d7c2dd20b190d413c0c6ddc3
container_end_page 3348
container_issue 12
container_start_page 3335
container_title Hepatology communications
container_volume 6
creator Wang, Xiaolin
Kim, Seung‐Jin
Guan, Yukun
Parker, Richard
Rodrigues, Robim M.
Feng, Dechun
Lu, Shelly C.
Gao, Bin
description Adipose tissue dysfunction is closely associated with the development and progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have implied an important role of prohibitin‐1 (PHB1) in adipose tissue function. In the current study, we aimed to explore the function of adipocyte PHB1 in the development and progression of NAFLD. The PHB1 protein levels in adipose tissues were markedly decreased in mice fed a high‐fat diet (HFD) compared to those fed a chow diet. To explore the function of adipocyte PHB1 in the progression of NAFLD, mice with adipocyte‐specific (adipo) deletion of Phb1 (Phb1adipo−/− mice) were generated. Notably, Phb1adipo−/− mice did not develop obesity but displayed severe liver steatosis under HFD feeding. Compared to HFD‐fed wild‐type (WT) mice, HFD‐fed Phb1adipo−/− mice displayed dramatically lower fat mass with significantly decreased levels of total adipose tissue inflammation, including macrophage and neutrophil number as well as the expression of inflammatory mediators. To our surprise, although liver steatosis in Phb1adipo−/− mice was much more severe, liver inflammation and fibrosis were similar to WT mice after HFD feeding. RNA sequencing analyses revealed that the interferon pathway was markedly suppressed while the bone morphogenetic protein 2 pathway was significantly up‐regulated in the liver of HFD‐fed Phb1adipo−/− mice compared with HFD‐fed WT mice. Conclusion: HFD‐fed Phb1adipo−/− mice display a subtype of the lean NAFLD phenotype with severe hepatic steatosis despite low adipose mass. This subtype of the lean NAFLD phenotype has similar inflammation and fibrosis as obese NAFLD in HFD‐fed WT mice; this is partially due to reduced total adipose tissue inflammation and the hepatic interferon pathway. Schematic illustration of the proposed role of adipocyte PHB1 in HFD‐induced NAFLD.
doi_str_mv 10.1002/hep4.2092
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_bbd7c2b7acd3476babc50995e6b7c67d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_bbd7c2b7acd3476babc50995e6b7c67d</doaj_id><sourcerecordid>2740257100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5092-f3e93a28a37e7daa4661e2892321539e8b892c558d7c2dd20b190d413c0c6ddc3</originalsourceid><addsrcrecordid>eNp1kc9O3DAQh6OqqCDg0BeoLPXUw4L_JHFyqVQBLUhIcKBSb9bYnmy8ysap49BuT32EPmOfpM4uRXDg5LH96RuPf1n2ltETRik_bXHITzit-avsgOeSLXiRf3v9pN7PjsdxRSllNWespm-yfVHytC3rg-zXOXYYne-JbwhYN3iziUiG4FunXXQ9YQR_gsGgIeJIWrds__7-00Ak1mFMpevtZNCSMSJEP7qR6CmS3kfSuXsMxPVNB-s1bJtAb0njdJi5o2yvgW7E44f1MPv6-eLu7HJxffPl6uzT9cIUaapFI7AWwCsQEqUFyMuSIa9qLjgrRI2VTrUpispKw63lVKcZbc6Eoaa01ojD7GrntR5WaghuDWGjPDi1PfBhqSBEZzpUWs8SLcFYkctSg57fUBdYamlKaZPr4841THqN1mAfA3TPpM9veteqpb9XtaQsr0QSvH8QBP99wjGqlZ9Cn-ZXXOaUFzKFmqgPO8qknxoDNo8dGFVz6mpOXc2pJ_bd0yc9kv8zTsDpDvjhOty8bFKXF7f5VvkPg8i7PA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2740257100</pqid></control><display><type>article</type><title>Deletion of adipocyte prohibitin 1 exacerbates high‐fat diet‐induced steatosis but not liver inflammation and fibrosis</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Wang, Xiaolin ; Kim, Seung‐Jin ; Guan, Yukun ; Parker, Richard ; Rodrigues, Robim M. ; Feng, Dechun ; Lu, Shelly C. ; Gao, Bin</creator><creatorcontrib>Wang, Xiaolin ; Kim, Seung‐Jin ; Guan, Yukun ; Parker, Richard ; Rodrigues, Robim M. ; Feng, Dechun ; Lu, Shelly C. ; Gao, Bin</creatorcontrib><description>Adipose tissue dysfunction is closely associated with the development and progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have implied an important role of prohibitin‐1 (PHB1) in adipose tissue function. In the current study, we aimed to explore the function of adipocyte PHB1 in the development and progression of NAFLD. The PHB1 protein levels in adipose tissues were markedly decreased in mice fed a high‐fat diet (HFD) compared to those fed a chow diet. To explore the function of adipocyte PHB1 in the progression of NAFLD, mice with adipocyte‐specific (adipo) deletion of Phb1 (Phb1adipo−/− mice) were generated. Notably, Phb1adipo−/− mice did not develop obesity but displayed severe liver steatosis under HFD feeding. Compared to HFD‐fed wild‐type (WT) mice, HFD‐fed Phb1adipo−/− mice displayed dramatically lower fat mass with significantly decreased levels of total adipose tissue inflammation, including macrophage and neutrophil number as well as the expression of inflammatory mediators. To our surprise, although liver steatosis in Phb1adipo−/− mice was much more severe, liver inflammation and fibrosis were similar to WT mice after HFD feeding. RNA sequencing analyses revealed that the interferon pathway was markedly suppressed while the bone morphogenetic protein 2 pathway was significantly up‐regulated in the liver of HFD‐fed Phb1adipo−/− mice compared with HFD‐fed WT mice. Conclusion: HFD‐fed Phb1adipo−/− mice display a subtype of the lean NAFLD phenotype with severe hepatic steatosis despite low adipose mass. This subtype of the lean NAFLD phenotype has similar inflammation and fibrosis as obese NAFLD in HFD‐fed WT mice; this is partially due to reduced total adipose tissue inflammation and the hepatic interferon pathway. Schematic illustration of the proposed role of adipocyte PHB1 in HFD‐induced NAFLD.</description><identifier>ISSN: 2471-254X</identifier><identifier>EISSN: 2471-254X</identifier><identifier>DOI: 10.1002/hep4.2092</identifier><identifier>PMID: 36200169</identifier><language>eng</language><publisher>United States: Wolters Kluwer Health Medical Research, Lippincott Williams &amp; Wilkins</publisher><subject>Adipocytes ; Adipocytes - metabolism ; Animals ; Blood tests ; Body fat ; Diet ; Diet, High-Fat - adverse effects ; Fatty acids ; Fibrosis ; Glucose ; Hepatitis ; Inflammation ; Inflammation - metabolism ; Interferons ; Liver cancer ; Liver diseases ; Mice ; Non-alcoholic Fatty Liver Disease - etiology ; Obesity ; Obesity - genetics ; Original ; Pathogenesis ; Polymerase chain reaction ; Prohibitins ; Protein expression ; Proteins ; Roles ; Statistical analysis ; Thermogenesis</subject><ispartof>Hepatology communications, 2022-12, Vol.6 (12), p.3335-3348</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. This article has been contributed to by US Government employees and their work is in the public domain in the USA.</rights><rights>2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. This article has been contributed to by US Government employees and their work is in the public domain in the USA.</rights><rights>2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5092-f3e93a28a37e7daa4661e2892321539e8b892c558d7c2dd20b190d413c0c6ddc3</citedby><cites>FETCH-LOGICAL-c5092-f3e93a28a37e7daa4661e2892321539e8b892c558d7c2dd20b190d413c0c6ddc3</cites><orcidid>0000-0003-4888-8670 ; 0000-0002-0505-2972</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2740257100/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2740257100?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,11543,25734,27905,27906,36993,44571,46033,46457,53772,53774,74875</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36200169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Xiaolin</creatorcontrib><creatorcontrib>Kim, Seung‐Jin</creatorcontrib><creatorcontrib>Guan, Yukun</creatorcontrib><creatorcontrib>Parker, Richard</creatorcontrib><creatorcontrib>Rodrigues, Robim M.</creatorcontrib><creatorcontrib>Feng, Dechun</creatorcontrib><creatorcontrib>Lu, Shelly C.</creatorcontrib><creatorcontrib>Gao, Bin</creatorcontrib><title>Deletion of adipocyte prohibitin 1 exacerbates high‐fat diet‐induced steatosis but not liver inflammation and fibrosis</title><title>Hepatology communications</title><addtitle>Hepatol Commun</addtitle><description>Adipose tissue dysfunction is closely associated with the development and progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have implied an important role of prohibitin‐1 (PHB1) in adipose tissue function. In the current study, we aimed to explore the function of adipocyte PHB1 in the development and progression of NAFLD. The PHB1 protein levels in adipose tissues were markedly decreased in mice fed a high‐fat diet (HFD) compared to those fed a chow diet. To explore the function of adipocyte PHB1 in the progression of NAFLD, mice with adipocyte‐specific (adipo) deletion of Phb1 (Phb1adipo−/− mice) were generated. Notably, Phb1adipo−/− mice did not develop obesity but displayed severe liver steatosis under HFD feeding. Compared to HFD‐fed wild‐type (WT) mice, HFD‐fed Phb1adipo−/− mice displayed dramatically lower fat mass with significantly decreased levels of total adipose tissue inflammation, including macrophage and neutrophil number as well as the expression of inflammatory mediators. To our surprise, although liver steatosis in Phb1adipo−/− mice was much more severe, liver inflammation and fibrosis were similar to WT mice after HFD feeding. RNA sequencing analyses revealed that the interferon pathway was markedly suppressed while the bone morphogenetic protein 2 pathway was significantly up‐regulated in the liver of HFD‐fed Phb1adipo−/− mice compared with HFD‐fed WT mice. Conclusion: HFD‐fed Phb1adipo−/− mice display a subtype of the lean NAFLD phenotype with severe hepatic steatosis despite low adipose mass. This subtype of the lean NAFLD phenotype has similar inflammation and fibrosis as obese NAFLD in HFD‐fed WT mice; this is partially due to reduced total adipose tissue inflammation and the hepatic interferon pathway. Schematic illustration of the proposed role of adipocyte PHB1 in HFD‐induced NAFLD.</description><subject>Adipocytes</subject><subject>Adipocytes - metabolism</subject><subject>Animals</subject><subject>Blood tests</subject><subject>Body fat</subject><subject>Diet</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Fatty acids</subject><subject>Fibrosis</subject><subject>Glucose</subject><subject>Hepatitis</subject><subject>Inflammation</subject><subject>Inflammation - metabolism</subject><subject>Interferons</subject><subject>Liver cancer</subject><subject>Liver diseases</subject><subject>Mice</subject><subject>Non-alcoholic Fatty Liver Disease - etiology</subject><subject>Obesity</subject><subject>Obesity - genetics</subject><subject>Original</subject><subject>Pathogenesis</subject><subject>Polymerase chain reaction</subject><subject>Prohibitins</subject><subject>Protein expression</subject><subject>Proteins</subject><subject>Roles</subject><subject>Statistical analysis</subject><subject>Thermogenesis</subject><issn>2471-254X</issn><issn>2471-254X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kc9O3DAQh6OqqCDg0BeoLPXUw4L_JHFyqVQBLUhIcKBSb9bYnmy8ysap49BuT32EPmOfpM4uRXDg5LH96RuPf1n2ltETRik_bXHITzit-avsgOeSLXiRf3v9pN7PjsdxRSllNWespm-yfVHytC3rg-zXOXYYne-JbwhYN3iziUiG4FunXXQ9YQR_gsGgIeJIWrds__7-00Ak1mFMpevtZNCSMSJEP7qR6CmS3kfSuXsMxPVNB-s1bJtAb0njdJi5o2yvgW7E44f1MPv6-eLu7HJxffPl6uzT9cIUaapFI7AWwCsQEqUFyMuSIa9qLjgrRI2VTrUpispKw63lVKcZbc6Eoaa01ojD7GrntR5WaghuDWGjPDi1PfBhqSBEZzpUWs8SLcFYkctSg57fUBdYamlKaZPr4841THqN1mAfA3TPpM9veteqpb9XtaQsr0QSvH8QBP99wjGqlZ9Cn-ZXXOaUFzKFmqgPO8qknxoDNo8dGFVz6mpOXc2pJ_bd0yc9kv8zTsDpDvjhOty8bFKXF7f5VvkPg8i7PA</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Wang, Xiaolin</creator><creator>Kim, Seung‐Jin</creator><creator>Guan, Yukun</creator><creator>Parker, Richard</creator><creator>Rodrigues, Robim M.</creator><creator>Feng, Dechun</creator><creator>Lu, Shelly C.</creator><creator>Gao, Bin</creator><general>Wolters Kluwer Health Medical Research, Lippincott Williams &amp; Wilkins</general><general>John Wiley and Sons Inc</general><general>Wolters Kluwer Health/LWW</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4888-8670</orcidid><orcidid>https://orcid.org/0000-0002-0505-2972</orcidid></search><sort><creationdate>202212</creationdate><title>Deletion of adipocyte prohibitin 1 exacerbates high‐fat diet‐induced steatosis but not liver inflammation and fibrosis</title><author>Wang, Xiaolin ; Kim, Seung‐Jin ; Guan, Yukun ; Parker, Richard ; Rodrigues, Robim M. ; Feng, Dechun ; Lu, Shelly C. ; Gao, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5092-f3e93a28a37e7daa4661e2892321539e8b892c558d7c2dd20b190d413c0c6ddc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adipocytes</topic><topic>Adipocytes - metabolism</topic><topic>Animals</topic><topic>Blood tests</topic><topic>Body fat</topic><topic>Diet</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Fatty acids</topic><topic>Fibrosis</topic><topic>Glucose</topic><topic>Hepatitis</topic><topic>Inflammation</topic><topic>Inflammation - metabolism</topic><topic>Interferons</topic><topic>Liver cancer</topic><topic>Liver diseases</topic><topic>Mice</topic><topic>Non-alcoholic Fatty Liver Disease - etiology</topic><topic>Obesity</topic><topic>Obesity - genetics</topic><topic>Original</topic><topic>Pathogenesis</topic><topic>Polymerase chain reaction</topic><topic>Prohibitins</topic><topic>Protein expression</topic><topic>Proteins</topic><topic>Roles</topic><topic>Statistical analysis</topic><topic>Thermogenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Xiaolin</creatorcontrib><creatorcontrib>Kim, Seung‐Jin</creatorcontrib><creatorcontrib>Guan, Yukun</creatorcontrib><creatorcontrib>Parker, Richard</creatorcontrib><creatorcontrib>Rodrigues, Robim M.</creatorcontrib><creatorcontrib>Feng, Dechun</creatorcontrib><creatorcontrib>Lu, Shelly C.</creatorcontrib><creatorcontrib>Gao, Bin</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Free Archive</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Hepatology communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Xiaolin</au><au>Kim, Seung‐Jin</au><au>Guan, Yukun</au><au>Parker, Richard</au><au>Rodrigues, Robim M.</au><au>Feng, Dechun</au><au>Lu, Shelly C.</au><au>Gao, Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deletion of adipocyte prohibitin 1 exacerbates high‐fat diet‐induced steatosis but not liver inflammation and fibrosis</atitle><jtitle>Hepatology communications</jtitle><addtitle>Hepatol Commun</addtitle><date>2022-12</date><risdate>2022</risdate><volume>6</volume><issue>12</issue><spage>3335</spage><epage>3348</epage><pages>3335-3348</pages><issn>2471-254X</issn><eissn>2471-254X</eissn><abstract>Adipose tissue dysfunction is closely associated with the development and progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have implied an important role of prohibitin‐1 (PHB1) in adipose tissue function. In the current study, we aimed to explore the function of adipocyte PHB1 in the development and progression of NAFLD. The PHB1 protein levels in adipose tissues were markedly decreased in mice fed a high‐fat diet (HFD) compared to those fed a chow diet. To explore the function of adipocyte PHB1 in the progression of NAFLD, mice with adipocyte‐specific (adipo) deletion of Phb1 (Phb1adipo−/− mice) were generated. Notably, Phb1adipo−/− mice did not develop obesity but displayed severe liver steatosis under HFD feeding. Compared to HFD‐fed wild‐type (WT) mice, HFD‐fed Phb1adipo−/− mice displayed dramatically lower fat mass with significantly decreased levels of total adipose tissue inflammation, including macrophage and neutrophil number as well as the expression of inflammatory mediators. To our surprise, although liver steatosis in Phb1adipo−/− mice was much more severe, liver inflammation and fibrosis were similar to WT mice after HFD feeding. RNA sequencing analyses revealed that the interferon pathway was markedly suppressed while the bone morphogenetic protein 2 pathway was significantly up‐regulated in the liver of HFD‐fed Phb1adipo−/− mice compared with HFD‐fed WT mice. Conclusion: HFD‐fed Phb1adipo−/− mice display a subtype of the lean NAFLD phenotype with severe hepatic steatosis despite low adipose mass. This subtype of the lean NAFLD phenotype has similar inflammation and fibrosis as obese NAFLD in HFD‐fed WT mice; this is partially due to reduced total adipose tissue inflammation and the hepatic interferon pathway. Schematic illustration of the proposed role of adipocyte PHB1 in HFD‐induced NAFLD.</abstract><cop>United States</cop><pub>Wolters Kluwer Health Medical Research, Lippincott Williams &amp; Wilkins</pub><pmid>36200169</pmid><doi>10.1002/hep4.2092</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-4888-8670</orcidid><orcidid>https://orcid.org/0000-0002-0505-2972</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2471-254X
ispartof Hepatology communications, 2022-12, Vol.6 (12), p.3335-3348
issn 2471-254X
2471-254X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_bbd7c2b7acd3476babc50995e6b7c67d
source Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content Database; PubMed Central
subjects Adipocytes
Adipocytes - metabolism
Animals
Blood tests
Body fat
Diet
Diet, High-Fat - adverse effects
Fatty acids
Fibrosis
Glucose
Hepatitis
Inflammation
Inflammation - metabolism
Interferons
Liver cancer
Liver diseases
Mice
Non-alcoholic Fatty Liver Disease - etiology
Obesity
Obesity - genetics
Original
Pathogenesis
Polymerase chain reaction
Prohibitins
Protein expression
Proteins
Roles
Statistical analysis
Thermogenesis
title Deletion of adipocyte prohibitin 1 exacerbates high‐fat diet‐induced steatosis but not liver inflammation and fibrosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A18%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deletion%20of%20adipocyte%20prohibitin%201%20exacerbates%20high%E2%80%90fat%20diet%E2%80%90induced%20steatosis%20but%20not%20liver%20inflammation%20and%20fibrosis&rft.jtitle=Hepatology%20communications&rft.au=Wang,%20Xiaolin&rft.date=2022-12&rft.volume=6&rft.issue=12&rft.spage=3335&rft.epage=3348&rft.pages=3335-3348&rft.issn=2471-254X&rft.eissn=2471-254X&rft_id=info:doi/10.1002/hep4.2092&rft_dat=%3Cproquest_doaj_%3E2740257100%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5092-f3e93a28a37e7daa4661e2892321539e8b892c558d7c2dd20b190d413c0c6ddc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2740257100&rft_id=info:pmid/36200169&rfr_iscdi=true